Related news for:  

Mater people have made an outstanding impression at the annual University of Queensland Faculty of Medicine Excellence Awards.

19

Dec

Mater awarded for medical and research excellence

In the recent NHMRC Ideas and Investigator Grant rounds, Mater Research was successful in obtaining funding for five research grants totaling $6.6 million.

18

Dec

Mater Receives $6.6 million in new funding

Dr Joshua Tobin a haematologist-in-training at Mater has been awarded the prestigious 2019 Celgene Future Leaders in Hematology Award in Orlando, Florida on Saturday 7 December.

17

Dec

Dr Josh Tobin receives 2019 Celgene Award

Professor Brian Gabrielli and team seek out the to answer a question—what is broken in melanomas that allows the damage to accumulate rather than repair, leading to mutations?

02

Dec

New light in melanoma research

Mater Hospital is leading the way in cutting-edge health and medical research at the Research Australia Awards.

27

Nov

Mater Shines at Research Australia Awards

Collaboration between clinical research institutes the Griffith Institute for Drug Discovery, Mater Research and Translational Research Institute has led to a breakthrough in cancer research.

25

Nov

Brisbane Based Breakthrough in Cancer Research

The Annual Mater Research Awards and Young Investigator Symposium has been held in Brisbane this week recognising the significant contribution of seasoned and emerging Mater researcher talent.

21

Nov

Mater Research Awards and Young Investigator Symposium

Mater Researcher Dr Felicity Davis has been awarded one of two $50,000 Metcalf Prizes from the National Stem Cell Foundation of Australia.

05

Nov

Dr Felicity Davis awarded Metcalf prize

A new spin-out from The University of Queensland will develop a novel therapy for the growing problem of obesity-related liver disease with the support of an initial investment from IP Group.

30

Oct

MRI-UQ discoveries translated from the lab into a spin-out company with real-world application

Mater Research CEO Professor Maher Gandhi has been appointed to a new National Blood Cancer Taskforce to deliver Australia’s first National Strategic Action Plan for Blood Cancer.

04

Sep

Mater Research CEO appointed to new National Blood Cancer Taskforce

Mater researcher Dr Vicki Clifton and Mater Centre for Neuroscience’s Dr Lisa Gillinder have been recognised for their achievements at the 22nd annual Women in Technology (WiT) Awards.

02

Sep

Mater researchers recognised at Women in Technology awards

Mater Research CEO and MRI-UQ Director Professor Maher Gandhi and his team report that immune-infiltration is a promising tool to improve outcomes for patients with follicular lymphoma.

29

Aug

Immune infiltration 'promising tool' to improve outcomes for follicular lymphoma

 |<  <  4 - 5 - 6 - 7 - 8 - 9 - 10 - 11 - 12 - 13  >  >|